Home India's BDR Pharma seeks licence to sell version of Bristol-Myers Squibb cancer drug
 

Keywords :   


India's BDR Pharma seeks licence to sell version of Bristol-Myers Squibb cancer drug

2013-03-18 16:20:28| Biotech - Topix.net

India's BDR Pharmaceuticals International Pvt Ltd has applied to the Indian patents office, seeking permission to sell a generic version of Bristol-Myers Squibb Co's cancer drug, dasatinib, through a so-called compulsory licence mechanism, a BDR executive said on Monday.

Tags: version sell drug cancer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.11SCR
28.1146
28.11BOSS OD-2 TURBO Over Drive
28.11/ Pulling the Plug
28.11
28.1110
28.112.5 120
28.11MSV-R
More »